Funding level: Maximum of $75,000 may be requested
Period: Up to 1 year of support is available
Description: Pilot awards are intended to test new hypotheses or technologies that have the potential to significantly advance our understanding and/or treatment of CCLA, GLA, GSD, or KLA. Preliminary data are required.
Areas of interest include, but are not limited to, genetic analysis, biomarker identification, preclinical model development and characterization, imaging, and single-cell RNA sequencing of animal or patient samples.
How to apply: Submit a letter of intent (LOI) to the LMI. If your LOI is selected, you will be invited to submit a full grant application.
LOIs are due by March 21, 2025. LOIs should be submitted to grants@lmiresearch.org by 11:59 PM CST.
Invitations for full application will be sent by March 26, 2025. Full applications are due May 30, 2025.
Pilot Award Submission Dates and Times
March 21, 2025: Deadline to submit your letter of intent (LOI) for Pilot and Established Investigator Awards. LOIs should be submitted to grants@lmiresearch.org by 11:59 PM CST.
March 26, 2025: Invitations will be extended to select investigators to submit a full grant application.
May 30, 2025: Deadline for invited investigators to submit their grant proposals. Proposals should be submitted to grants@lmiresearch.org by 11:59 PM CST.
August 31, 2025: Applicants will be notified by this date. Once the paperwork has been signed, funding is anticipated to begin October 1, 2025.
This pilot grant is intended to encourage exploratory research, to develop and test exciting new hypotheses or research approaches that have the potential to significantly advance our understanding and/or treatment of CCLA, GLA, GSD, or KLA.
Sponsor Institute/Organizations: Lymphatic Education & Research Network
Address: 7475 Wisconsin Ave Suite 1100, Bethesda, MD 20814, USA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 21, 2025
May 30, 2025
$75,000
Affiliation: Lymphatic Education & Research Network
Address: 7475 Wisconsin Ave Suite 1100, Bethesda, MD 20814, USA
Website URL: https://www.lmiresearch.org/apply-for-funding/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.